Fig. 8From: Efficacy and safety of IDH inhibitors in IDH-mutated cancers: a systematic review and meta-analysis of 4 randomized controlled trialsMeta-analysis of the TRAEs ≥ 3 of IDH inhibitors in IDH-mutated cancersBack to article page
